Sulpiride addition for the treatment of clozapine-induced hypersalivation: Preliminary study

Israel Journal of Psychiatry and Related Sciences

Volumn 42, Issue 1, 2005, Pages 61-63

  Kreinin, Anatoly ^a   Epshtein, Svetlana ^a   Sheinkman, Ayala ^a   Tell, Emanuel ^a  

^a Technion Medical School   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23844535087     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hofer A, Hummer M, Kemmler G, Kurz M, Kurzthaler I, Fleischhacker WW. The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia. Int J Neuropsychopharmacol 2003;6:201-206.
2. Iqbal MM, Rahman A, Husain Z, Mahmud SZ, Ryan WG, Feldman JM. Clozapine: A clinical review of adverse effects and management. Ann Clin Psychiatry 2003;15:33-48.
3. Davydov L, Botts SR. Clozapine-induced hypersalivation. Ann Pharmacother 2000; 34:662-665.
4. Robinson D, Fenn H, Yesavage J. Possible association of parotitis with clozapine. Am J Psychiatry 1995;152:297-298.
5. Brodkin ES, Pelton GH, Price LH. Treatment of clozapine-induced parotid gland swelling. Am J Psychiatry 1996;153:445.
6. Conry A, Siris SG, Bermanzohn PC. Improvement of clozapine-induced sialorrhea after septoplasty. Am J Psychiatry 1996;153:444.
7. Calderon J, Rubin E, Sobota WL. Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: A preliminary report. Int Clin Psychopharmacol 2000;15:49-52.
8. Spivak B, Adlersberg S, Rosen L, Gonen N, Mester R, Weizman A. Trihexyphenidyl treatment of clozapine-induced hypersalivation. Int Clin Psychopharmacol 1997;12:213-215.
9. Corrigan FM, MacDonald S, Reynolds GP. Clozapine-induced hypersalivation and the alpha 2 adrenoceptor. Br J Psychiatry 1995;167:412.
10. Grabowski J. Clonidine treatment of clozapine-induced hypersalivation. J Clin Psychopharmacol 1992;12:69-70.
11. Fritze J, Elliger T. Pirenzepine for clozapine-induced hypersalivation. Lancet 1995; 346:1034.
12. Bai YM, Lin CC, Chen JY, Liu WC. Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: A randomized, double-blind, placebo-controlled, cross-over study. J Clin Psychopharmacol 2001;21:608-611.
13. Shiloh R, Zemishlany Z, Aizenberg D, Radwan M, Schwartz B, Dorfman-Etrog P, Modai I, Khaikin M, Weizman A. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study. Br J Psychiatry 1997; 171:569-573.
14. st ed. Philadelphia: W.B. Saunders, 1989: pp. 737-743.
15. Schuster P, Gabriel E, Kufferle B, Strobl G, Karobath M. Reversal by physostigmine of clozapine-induced delirium. Clin Toxicol 1977;10:437-441.
16. Baldessarini RJ, Huston-Lyons D, Campbell A, Marsh E, Cohen BM. Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br J Psychiatry Suppl 1992:12-16.